Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group
(Q28293763)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||
| (P304) |
1268-76
|
||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||
| (P433) |
7
|
||||||||||||||||||||
| (P478) |
45
|
||||||||||||||||||||
| (P577) |
+1995-07-00T00:00:00Z
|
||||||||||||||||||||
| (P921) |
(Q42824827)
(Q269829) (Q6934595) (Q12131) (Q18555066) (Q8277) |
||||||||||||||||||||
| (P1433) |
(Q1161692)
|
||||||||||||||||||||
| (P1476) |
"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group" (language: en)
|
||||||||||||||||||||
| (P2093) |
K P Johnson
B R Brooks
J A Cohen
C C Ford
J Goldstein
R P Lisak
L W Myers
H S Panitch
J W Rose
R B Schiffer
|